Aadi Bioscience Inc.

Aadi is a commercial-stage biopharmaceutical company focused on precision therapies, with the primary goal of bringing transformational therapies to cancer patients. In November 2021, Aadi received FDA approval for FYARRO®, and announced the commercial launch in February 2022.